Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
Abstract In cancer patients, circulating cell-free DNA (cfDNA) includes tumor-derived DNA (tDNA). cfDNA has been used clinically for non-invasive gene mutation testing. The aim of this study was to characterize the features of the genetic alterations detected in cfDNA. This study included 6 patients...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad43e947b89543268697b1f2e5f2c70a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ad43e947b89543268697b1f2e5f2c70a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ad43e947b89543268697b1f2e5f2c70a2021-12-02T14:30:40ZMolecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis10.1038/s41598-021-87094-12045-2322https://doaj.org/article/ad43e947b89543268697b1f2e5f2c70a2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87094-1https://doaj.org/toc/2045-2322Abstract In cancer patients, circulating cell-free DNA (cfDNA) includes tumor-derived DNA (tDNA). cfDNA has been used clinically for non-invasive gene mutation testing. The aim of this study was to characterize the features of the genetic alterations detected in cfDNA. This study included 6 patients with primary lung cancer who died due to cancer progression. Tumors were biopsied at autopsy. Genetic alteration profiles were obtained using next generation sequencing. The features of the tDNA genetic alterations detected in cfDNA included a higher frequency of being present in multiple tumors (67% truncal mutations, 36% shared mutations, and 4% individual mutations) and a higher variant allele frequency (VAF; 47.6% versus 4.1% for tDNA alterations detected in cfDNA versus not detected in cfDNA, respectively). The data revealed that the tumor-derived genetic alterations most easily detected in cfDNA were truncal mutations with a high VAF. These results showed that essential genetic alterations enriched in cfDNA could help to characterize cancer cells and that genetic testing using cfDNA has advantages in the detection of fundamental regulatory aberrations occurring during tumorigenesis.Hayato KobaHideharu KimuraTaro YonedaTakashi SoneNoriyuki OhkuraJohsuke HaraKazuyoshi HosomichiAtsushi TajimaKazuo KasaharaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Hayato Koba Hideharu Kimura Taro Yoneda Takashi Sone Noriyuki Ohkura Johsuke Hara Kazuyoshi Hosomichi Atsushi Tajima Kazuo Kasahara Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis |
description |
Abstract In cancer patients, circulating cell-free DNA (cfDNA) includes tumor-derived DNA (tDNA). cfDNA has been used clinically for non-invasive gene mutation testing. The aim of this study was to characterize the features of the genetic alterations detected in cfDNA. This study included 6 patients with primary lung cancer who died due to cancer progression. Tumors were biopsied at autopsy. Genetic alteration profiles were obtained using next generation sequencing. The features of the tDNA genetic alterations detected in cfDNA included a higher frequency of being present in multiple tumors (67% truncal mutations, 36% shared mutations, and 4% individual mutations) and a higher variant allele frequency (VAF; 47.6% versus 4.1% for tDNA alterations detected in cfDNA versus not detected in cfDNA, respectively). The data revealed that the tumor-derived genetic alterations most easily detected in cfDNA were truncal mutations with a high VAF. These results showed that essential genetic alterations enriched in cfDNA could help to characterize cancer cells and that genetic testing using cfDNA has advantages in the detection of fundamental regulatory aberrations occurring during tumorigenesis. |
format |
article |
author |
Hayato Koba Hideharu Kimura Taro Yoneda Takashi Sone Noriyuki Ohkura Johsuke Hara Kazuyoshi Hosomichi Atsushi Tajima Kazuo Kasahara |
author_facet |
Hayato Koba Hideharu Kimura Taro Yoneda Takashi Sone Noriyuki Ohkura Johsuke Hara Kazuyoshi Hosomichi Atsushi Tajima Kazuo Kasahara |
author_sort |
Hayato Koba |
title |
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis |
title_short |
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis |
title_full |
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis |
title_fullStr |
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis |
title_full_unstemmed |
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis |
title_sort |
molecular features of tumor-derived genetic alterations in circulating cell-free dna in virtue of autopsy analysis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ad43e947b89543268697b1f2e5f2c70a |
work_keys_str_mv |
AT hayatokoba molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT hideharukimura molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT taroyoneda molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT takashisone molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT noriyukiohkura molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT johsukehara molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT kazuyoshihosomichi molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT atsushitajima molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis AT kazuokasahara molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis |
_version_ |
1718391213250314240 |